Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (35 ops.)
Latest filing published 23 Jun 2026 for NOVAVAX INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
35
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Gregg H. Alton: trading record in brief
This profile gathers the share dealings of Gregg H. Alton across 2 companies, led by Gilead Sciences, Inc. and Novavax Inc. Over a trading history stretching from 15 February 2016 to 20 June 2026, the count stands at 72 filings.
No open-market purchase appears, only 35 sales worth €26.0M. Besides market trades, the filings include 17 share grants and 19 option exercises.
The record was last updated on 23 June 2026 with an option exercise in Novavax Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gregg H. Alton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
18,880 sharesCommon StockSEC:0001104659-26-076924:0
10,420 shares0Common StockSEC:0001593968-25-000783:0
3,420 shares@ US$4.90100.0% of flowCommon StockSEC:0001104659-25-009786:0
6,670 shares0Common StockSEC:0001593968-24-000864:0
3,100 sharesCommon StockSEC:0001209191-23-036741:0
700 sharesCommon StockSEC:0001209191-22-038590:0
6 of 6 declarations
